Fate Therapeutics
FATE
FATE
90 hedge funds and large institutions have $385M invested in Fate Therapeutics in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 11 closing their positions.
Holders
90
Holders Change
+12
Holders Change %
+15.38%
% of All Funds
2.07%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
24
Increased
35
Reduced
21
Closed
11
Calls
$1.26M
Puts
$594K
Net Calls
+$662K
Net Calls Change
+$624K
Top Buyers
1 |
1
BlackRock
New York
|
$28.3M |
2 |
RG
2
Redmile Group
San Francisco,
California
|
$65M |
3 |
AG
3
Artal Group
Luxembourg
|
$8.3M |
4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$9.4M |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$4.17M |